Linagliptin Tablets 5mg (Trazenta® / トラゼンタ錠5mg)

JPY ¥15,900

Japanese biliary-excreted selective DPP-4 inhibitor (Linagliptin 5mg). Oral once-daily tablet for the treatment of type 2 diabetes mellitus. 100 tablets [10 tablets (PTP) x 10]. Mfd. by Nippon Boehringer Ingelheim Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥14,628
10 - 19 12% JPY ¥13,992
20 + 18% JPY ¥13,038
SKU: TRZ-5-TAB Category:

Description

Product Overview / 商品概要

Trazenta Tablets 5mg (トラゼンタ錠5mg)
Generic: Linagliptin / リナグリプチン
Therapeutic Category: Biliary-excreted selective DPP-4 inhibitor / Type 2 diabetes mellitus treatment agent / 胆汁排泄型選択的DPP-4阻害剤 / 2型糖尿病治療剤
Manufactured by: Nippon Boehringer Ingelheim Co., Ltd. / 日本ベーリンガーインゲルハイム株式会社

Composition & Specification / 組成・規格

Active Ingredient: Linagliptin 5mg per tablet / 1錠中 リナグリプチン 5mg
Additives: D-Mannitol, Partially pregelatinized starch, Corn starch, Copovidone, Magnesium stearate, Hypromellose, Titanium dioxide, Talc, Macrogol 6000 NF, Ferric oxide / D-マンニトール、部分アルファー化デンプン、トウモロコシデンプン、コポビドン、ステアリン酸マグネシウム、ヒプロメロース、酸化チタン、タルク、マクロゴール6000NF、三二酸化鉄
Appearance: Light red film-coated tablet, diameter approx. 8mm, thickness approx. 3.5mm, weight approx. 185mg, identification code D5
外観: 淡赤色のフィルムコート錠、直径 約8mm、厚さ 約3.5mm、重さ 約185mg、識別コード D5

Indications / 効能効果

EN: Type 2 diabetes mellitus
JA: 2型糖尿病

Dosage and Administration / 用法用量

EN: The usual adult dose is 5mg of linagliptin administered orally once daily.
JA: 通常、成人にはリナグリプチンとして5mgを1日1回経口投与する。

Contraindications / 禁忌

EN: ①Patients with a history of hypersensitivity to any component of this product ②Patients with diabetic ketoacidosis, diabetic coma or pre-coma, or type 1 diabetes mellitus ③Patients with severe infections, before or after surgery, or with serious trauma
JA: ①本剤の成分に対し過敏症の既往歴のある患者 ②糖尿病性ケトアシドーシス、糖尿病性昏睡又は前昏睡、1型糖尿病の患者 ③重症感染症、手術前後、重篤な外傷のある患者

Regulatory Information / 規制情報

Approval No.: 22300AMX00605000
Sales Started: September 2011 / 2011年9月
Classification Code: 873969
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 100 tablets [10 tablets (PTP) x 10] / 100錠[10錠(PTP)×10]
Other Available Packages (by special order): 100 tablets [10 tablets (PTP) x 10], 500 tablets [10 tablets (PTP) x 50], 500 tablets [bottle, bulk, with desiccant]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Linagliptin Tablets 5mg (Trazenta® / トラゼンタ錠5mg)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Linagliptin Tablets 5mg (Trazenta®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.